2018 Agenda Highlights: Why was this be the best operationally focussed oncology conference on the West Coast this year?

1st January, 1970

2018 Agenda Highlights: Why was this be the best operationally focussed oncology conference on the West Coast this year?

Sharing insights on how to differentiate your oncology trial in a competitive landscape attracting both physicians and patients

The competition for oncology sites, staff and patients in this region is tremendous. The high competition makes recruitment even harder than it already is. Delayed patient recruitment and study start-up has detrimental effects on study budget and timelines.

Archana Sah, Therapeutic Area Leader, Oncology, Director, Clinical Operations at Genentech, discussed how to differentiate your trial in such a competitive landscape, making you stand out.

INTERACTIVE SESSION: Discussing the advantages and operational challenges associated with combination trials in oncology to improve efficiency and retention in your study

Franco Davi, Senior Clinical Program Leader at Genentech, hosted an interactive session whereby the audience came up with their biggest challenges and strategies for overcoming common hurdles within combination trials. This session gave the opportunity to ask questions and come up with the 5 best practices for completing a successful combination study.

PANEL DISCUSSION: Should your clinical oncology outsourcing model be Functional, Full-Service, or Hybrid?

Sameena Sharif, Vice President of Business Operations, Portfolio Planning and Project Management at Astex Pharmaceuticals, hosted a discussion with 3 industry leaders debating the best oncology outsourcing models. This panel explored the pros and cons of Hybrid vs Full-Service outsourcing strategies, to find the best model for you.

Balancing clinical trial perspectives by involving patients in the protocol design phase of oncology trials 

Making trials more patient-centric is something all companies are working towards. By aligning objectives of patients, sponsors and physicians we are able to increase patient engagement and retention in oncology studies.

Deborah Collyar, President of Patient Advocates In Research, discussed strategies for working towards a patient-focussed approach to oncology trials.


Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the

If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:

Paul Adams
+44 (0)20 7936 6948

Speaker opportunities

We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact:

Chloe Roberts
E: Chloe.Roberts@arena-international.com
T: +44 (0)207 936 6822